| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/21/2004 | CN1468865A Fusion protein of recombinant SARS virus N protein carboxyl terminal peptide section and GST and its prepn |
| 01/21/2004 | CN1468862A Technological process of producing recombinant human histiotype plasminogen activator TNK mutant |
| 01/21/2004 | CN1468861A Recombinant human immune deficiency virus fusion inhibitor and its prepn and use |
| 01/21/2004 | CN1135264C Process for producing L-methionine gamma-lyase crystals |
| 01/21/2004 | CN1135262C Process for high efficiently multiplying hepatitis C virus and carrier used for the same method |
| 01/20/2004 | US6680429 Starchless variety of pisum sativum having elevated levels of sucrose |
| 01/20/2004 | US6680428 Isolated nucleic acids encoding methylenetetrahydrofolate dehydrogenase enzymes |
| 01/20/2004 | US6680427 Chimeric gene encoding mlo-like polypeptide in sense or antisense orientation; gene expression, engineering; fungal diseases in plants |
| 01/20/2004 | US6680426 Expression vector for use in the transformation of plant organelles |
| 01/20/2004 | US6680425 Chimeric plant promoters comprising sugar-regulatory sequences |
| 01/20/2004 | US6680424 Modified proteinase inhibitors |
| 01/20/2004 | US6680380 Nucleic acids encoding mammalian interleukin-1ζ, related reagents and methods |
| 01/20/2004 | US6680378 Restriction endonuclease digest; gel electrophoresis; comparing staining intensity |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680373 Polypeptide for use in the human diagnostics and therapeutics |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680370 Diagnosing defective mesangial cells; glomerulosclerosis, nephritis, and diabetic nephropathy treatment |
| 01/20/2004 | US6680369 Nucleotide sequences coding protein for use in treatment cytoskeletal defects |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680296 Compositions comprising bouganin and a cell binding ligand are particularly useful to kill cells of a target population |
| 01/20/2004 | US6680209 Analyzing samples containing human anti-mouse antibodies (hama) or heterophilic antibodies |
| 01/20/2004 | US6680207 Detection of molecules in samples |
| 01/20/2004 | US6680199 Adding ionomycin to oocyte and preventing phosphorylation of the cellular proteins; adding serine-threonine kinase inhibitor such as 6-dimethylaminopurine |
| 01/20/2004 | US6680198 Engraftable human neural stem cells |
| 01/20/2004 | US6680191 Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B FAMILIES and uses thereof |
| 01/20/2004 | US6680190 Gene encoding phosphoglucoisomerase |
| 01/20/2004 | US6680189 (a disintegrin and metalloprotease) adam proteins; preventing or treating disc herniation, ischialgia, glomerular nephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis or osteoporosis |
| 01/20/2004 | US6680187 Nucleotide sequences coding for the PTSI protein |
| 01/20/2004 | US6680186 Nucleotide sequences which encode plsC gene |
| 01/20/2004 | US6680185 Plant polyphenol oxidase homologs |
| 01/20/2004 | US6680182 Promoter sequence operably linked to a dna sequence encoding first and second proteins linked by hinge regiion; tetanus toxin c fragments |
| 01/20/2004 | US6680179 Host/vector system for expression of membrane proteins |
| 01/20/2004 | US6680175 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 01/20/2004 | US6680171 Drug screening, genetic engineering |
| 01/20/2004 | US6680170 Polynucleotides encoding STE20-related protein kinases and methods of use |
| 01/20/2004 | US6680169 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 01/20/2004 | US6680060 A live hepatitis a virus adapted to growth in mrc-5 cells (human fibroblast-like cell line) |
| 01/20/2004 | US6680053 Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same |
| 01/20/2004 | US6678998 Floral packaging material having great masters prints thereon |
| 01/20/2004 | CA2264714C Method of sorting birds in ovo |
| 01/20/2004 | CA2210753C Farnesyl diphosphate synthase |
| 01/20/2004 | CA2155332C Polypeptide having cold-stable pyruvate, orthophosphate dikinase activity, dna encoding the same and recombinant vector and transformed plants containing the dna |
| 01/20/2004 | CA2148599C Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
| 01/20/2004 | CA2101534C Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 01/20/2004 | CA2090961C Specific binding agents |
| 01/19/2004 | CA2433485A1 Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 01/18/2004 | CA2432925A1 Enzymatic assay of hiv protease inhibitors |
| 01/16/2004 | CA2432940A1 Method for producing a microarray |
| 01/15/2004 | WO2004005927A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 01/15/2004 | WO2004005890A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 01/15/2004 | WO2004005555A1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 01/15/2004 | WO2004005554A2 Antisense modulation of livin expression |
| 01/15/2004 | WO2004005553A1 Apparatus and method for isolating a nucleic acid from a sample |
| 01/15/2004 | WO2004005552A1 Antisense modulation of tfg-beta 2 expression |
| 01/15/2004 | WO2004005551A1 Antisense modulation of nf-kappa-b p50 subunit expression |
| 01/15/2004 | WO2004005545A1 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 01/15/2004 | WO2004005544A2 Marker genes for determining renal toxicity |
| 01/15/2004 | WO2004005539A1 Diagnosis of sepsis using mitochondrial nucleic acid assays |
| 01/15/2004 | WO2004005538A1 Method of screening anticancer agent |
| 01/15/2004 | WO2004005535A2 Pathogenicity proteins which can be used as targets for developing means for preventing and controlling bacterial infections |
| 01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/15/2004 | WO2004005527A1 Microorganisms and processes for enhanced production of pantothenate |
| 01/15/2004 | WO2004005524A1 Hepatitis c virus particle formation |
| 01/15/2004 | WO2004005523A1 Recombinant poxvirus not having a functional 3beta-hsd gene |
| 01/15/2004 | WO2004005522A2 Plasmid vectors for transformation of filamentous fungi |
| 01/15/2004 | WO2004005521A1 Expression of the human igf-1 in transgenic plastids |
| 01/15/2004 | WO2004005520A1 Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants |
| 01/15/2004 | WO2004005519A1 Construction of a recombinant saccharomyces cerevisiae oenological yeast strain that overexpresses an endopolygalacturonase, which is intended for use in wine production |
| 01/15/2004 | WO2004005518A1 PURIFICATION, CLONING AND BIOCHEMICAL CHARACTERIZATION OF XendoU, ENDORIBONUCLEASIC ACTIVITY INVOLVED IN SMALL NUCLEAR RNA SPLICING-INDEPENDENT BIOSYNTHESIS IN XENOPUS LAEVIS |
| 01/15/2004 | WO2004005517A2 L-amidase from rhizobium huautlense |
| 01/15/2004 | WO2004005516A1 Use of ahas mutant genes as selection marker in potato transformation |
| 01/15/2004 | WO2004005515A1 Sterility recovery genes to rice bt type male sterile cytoplasm |
| 01/15/2004 | WO2004005514A1 Human protooncogene 6 and protein encoded therein |
| 01/15/2004 | WO2004005513A2 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/15/2004 | WO2004005511A1 Tumor-lysing virus growing selectively in tumor cells |
| 01/15/2004 | WO2004005508A1 Method of constructing recombinant plasmid |
| 01/15/2004 | WO2004005506A2 Bacterial cell digestion by means of domain 3 of ef-tu |
| 01/15/2004 | WO2004005505A1 A simple, efficient, and accelerated method for enzyme-catalyzed in vitro modification and synthesis of nucleic acid using microwave irradiation |
| 01/15/2004 | WO2004005504A1 Methods for obtaining pathogen resistance in plants |
| 01/15/2004 | WO2004005502A1 Programmed cell death used as a biological containment system |
| 01/15/2004 | WO2004005501A1 Regulation of human casein kinase i epsilon |
| 01/15/2004 | WO2004005500A1 Novel polypeptide having function of 7-keto-8-aminopelargonic acid synthase of plant and method for inducing growth inhibition and lethality by suppressing expression of the polypeptide |
| 01/15/2004 | WO2004005499A1 Glucose dehydrogenase |
| 01/15/2004 | WO2004005498A1 Chimeric gb virus b (gbv-b) |
| 01/15/2004 | WO2004005495A1 Novel airway epithelial cell line and use thereof |
| 01/15/2004 | WO2004005491A1 Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
| 01/15/2004 | WO2004005485A2 Compositions and methods for controlling parasitic nematodes |
| 01/15/2004 | WO2004005482A2 Methods and compositions for the production, identification and purification of fusion proteins |
| 01/15/2004 | WO2004005481A2 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | WO2004005480A2 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | WO2004005479A2 A high resolution typing system for pathogenic borrelia |
| 01/15/2004 | WO2004005476A2 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | WO2004005474A2 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | WO2004005473A2 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | WO2004005467A2 Expression of human interferon in transgenic chloroplasts |
| 01/15/2004 | WO2004005464A2 Compounds promoting delivery of genes |
| 01/15/2004 | WO2004005462A2 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 01/15/2004 | WO2004005461A2 Antisense modulation of insulin-like growth factor 2 expression |
| 01/15/2004 | WO2004005460A2 Antisense modulation of hmg-coa reductase expression |